Sveriges mest populära poddar
New Retina Radio by Eyetube
VetenskapTeknologi

ARCHWAY at AAO

14 min•18 november 2020

The Port Delivery System With Ranibizumab (Genentech) is under investigation for the treatment of wet AMD in the phase 3 ARCHWAY trial, data from which was shared at this year’s AAO Annual Meeting. Nancy Holekamp, MD, sits down with NRR to provide a primary analysis of the results of ARCHWAY and discusses safety outcomes. 


This editorially independent podcast is supported with advertising.

Fler avsnitt av New Retina Radio by Eyetube

Visa alla avsnitt av New Retina Radio by Eyetube
The Fellow Eye: Episode 6
•41 min
ASRS '26: SOL-1 and TRUCKEE at 4.5 Years
•24 min
New Retina Radio Journal Club w/ VBS: Clinical Features and Outcomes of IOFB Removal
•17 min
How EYP-1901 Addresses IL-6 Drivers in Wet AMD and DME
•29 min
Barriers to Care, Patient Education, and Treatment Decisions in Geographic Atrophy
•16 min
Evolving Practice Patterns and Dosing Strategies in Geographic Atrophy
•18 min
Biomarkers, Imaging, and Early Treatment Decisions in Geographic Atrophy
•14 min
The Fellow Eye: Episode 5
•39 min
Retinal Perfusion, Sensitivity, and Function in DR
•16 min
Spotlight on UNITY® VCS: Experience Extraordinary
•30 min

New Retina Radio by Eyetube med Retina Today finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.